Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact
Open Access
- 11 June 2022
- journal article
- research article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 86 (Pt 2) , 436-449
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- CCR6/CCL20 Chemokine Expression Profile in Distinct Colorectal MalignanciesScandinavian Journal of Immunology, 2013
- Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasisBritish Journal of Cancer, 2012
- Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivityin vitroandin vivoin colon cancer cell line modelsInternational Journal of Cancer, 2011
- Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastasesCancer Letters, 2011
- Immunity, Inflammation, and CancerCell, 2010
- CXCL10 expression and prognostic significance in stage II and III colorectal cancerMolecular Biology Reports, 2009
- Prognostic Significance of CXCL12 Expression in Patients With Colorectal CarcinomaAmerican Journal of Clinical Pathology, 2009
- The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancerInternational Journal of Cancer, 2009
- Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodesOncogene, 2007
- Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphomaLeukemia, 2003